Latex allergy in the workplace

Area of Science:

• Occupational Health
• Immunology
• Allergy Research

Background:

• Healthcare workers have a significantly higher prevalence of latex sensitization (8-12%) compared to the general population (<1%).
• Powdered natural rubber latex (NRL) gloves are a primary source of workplace exposure, leading to various clinical manifestations from irritant contact dermatitis to Type I hypersensitivity.
• Understanding NRL allergy is critical for protecting healthcare professionals from potentially severe allergic reactions.

Purpose of the Study:

• To review the diagnostic challenges and potential improvements for natural rubber latex (NRL) allergy.
• To explore the factors influencing sensitization and the development of diagnostic tools.
• To highlight the need for further research into epidemiological data and intervention strategies.

Main Methods:

• Review of clinical manifestations, diagnostic methods (skin prick testing, in vitro IgE assays), and factors affecting NRL allergy.
• Analysis of current limitations in diagnostic test accuracy, including variability in commercial assays and allergen components.
• Examination of in vivo and in vitro models used to study the development of latex sensitization and the role of exposure routes.

Main Results:

• Diagnosis of Type I NRL allergy relies on history and confirmatory tests, with in vitro IgE assays becoming critical due to limitations in skin prick testing extracts.
• Commercial IgE assays may show discrepancies due to detecting different NRL allergens (Hev b 1-10), impacting diagnostic accuracy.
• Murine models and in vitro studies indicate that skin condition and exposure route significantly influence latex sensitization and IgE production.

Conclusions:

• Improving diagnostic accuracy requires better understanding of NRL allergens and current diagnostic test performance.
• Further epidemiological studies are needed to define the scope and trends of latex allergy.
• Elucidating sensitization mechanisms through in vivo and in vitro models can inform workplace intervention strategies to reduce NRL allergy.